RG
CBAY
Redmile Group’s Cymabay Therapeutics CBAY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,719,247
| Closed | -$12.4M | – | 93 |
|
|
2020
Q3 | $12.4M | Buy |
1,719,247
+44,800
| +3% | +$324K | 0.23% | 65 |
|
|
2020
Q2 | $5.84M | Sell |
1,674,447
-1,076,169
| -39% | -$3.76M | 0.11% | 73 |
|
|
2020
Q1 | $4.07M | Sell |
2,750,616
-62,949
| -2% | -$93.2K | 0.11% | 60 |
|
|
2019
Q4 | $5.52M | Sell |
2,813,565
-302,300
| -10% | -$593K | 0.13% | 59 |
|
|
2019
Q3 | $16M | Sell |
3,115,865
-22,500
| -0.7% | -$115K | 0.53% | 46 |
|
|
2019
Q2 | $22.5M | Buy |
3,138,365
+194,600
| +7% | +$1.39M | 0.64% | 47 |
|
|
2019
Q1 | $39.1M | Sell |
2,943,765
-5,100
| -0.2% | -$67.7K | 1.14% | 26 |
|
|
2018
Q4 | $23.2M | Sell |
2,948,865
-44,700
| -1% | -$352K | 0.93% | 35 |
|
|
2018
Q3 | $33.2M | Buy |
2,993,565
+35,800
| +1% | +$397K | 1.02% | 34 |
|
|
2018
Q2 | $39.7M | Buy |
2,957,765
+2,200
| +0.1% | +$29.5K | 1.35% | 26 |
|
|
2018
Q1 | $38.4M | Buy |
2,955,565
+953,300
| +48% | +$12.4M | 1.48% | 26 |
|
|
2017
Q4 | $18.4M | Buy |
2,002,265
+355,165
| +22% | +$3.27M | 0.8% | 41 |
|
|
2017
Q3 | $13.3M | Buy |
+1,647,100
| New | +$13.3M | 0.65% | 41 |
|